COM:TONIXPHARMA
Tonix Pharmaceuticals
- Stock
Last Close
0.20
22/11 21:00
Market Cap
6.10M
Beta: -
Volume Today
1.92M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | 7.77M - | ||||||||||
cost of revenue | 27.66M - | 48.16M 74.15% | 38.97M 19.09% | 21.29M 45.36% | 26.32M 23.63% | 28.83M 9.52% | 50.51M 75.22% | 92.31M 82.76% | 112.09M 21.43% | 4.74M 95.77% | |
gross profit | -27.66M - | -48.16M 74.15% | -38.97M 19.09% | -21.29M 45.36% | -26.32M 23.63% | -28.83M 9.52% | -50.51M 75.22% | -92.31M 82.76% | -112.09M 21.43% | 3.03M 102.70% | |
selling and marketing expenses | |||||||||||
general and administrative expenses | 9.04M - | 12.66M 40.04% | 10.44M 17.55% | 7.95M 23.83% | 8.76M 10.25% | 10.64M 21.36% | 14.35M 34.96% | 23.47M 63.54% | 30.21M 28.72% | 34.75M 15.02% | |
selling general and administrative expenses | 9.04M - | 12.66M 40.04% | 10.44M 17.55% | 7.95M 23.83% | 8.76M 10.25% | 10.64M 21.36% | 14.35M 34.96% | 23.47M 63.54% | 30.21M 28.72% | 34.75M 15.02% | |
research and development expenses | 18.62M - | 35.50M 90.71% | 28.53M 19.63% | 13.34M 53.24% | 17.56M 31.60% | 18.19M 3.61% | 36.16M 98.75% | 68.84M 90.39% | 81.88M 18.94% | 86.66M 5.84% | |
other expenses | |||||||||||
cost and expenses | 27.66M - | 48.16M 74.15% | 38.97M 19.09% | 21.29M 45.36% | 26.32M 23.63% | 28.83M 9.52% | 50.51M 75.22% | 92.31M 82.76% | 112.09M 21.43% | 126.15M 12.54% | |
operating expenses | 27.66M - | 48.16M 74.15% | 38.97M 19.09% | 21.29M 45.36% | 26.32M 23.63% | 28.83M 9.52% | 50.51M 75.22% | 92.31M 82.76% | 112.09M 21.43% | 121.41M 8.31% | |
interest expense | -7.91M - | ||||||||||
ebitda | -27.66M - | -48.16M 74.15% | -38.97M 19.09% | -21.29M 45.36% | -26.32M 23.63% | -28.83M 9.52% | -50.51M 75.22% | -92.31M 82.76% | -112.09M 21.43% | -118.38M 5.61% | |
operating income | -27.66M - | -48.16M 74.15% | -38.97M 19.09% | -21.29M 45.36% | -26.32M 23.63% | -28.83M 9.52% | -50.51M 75.22% | -92.31M 82.76% | -112.09M 21.43% | -118.38M 5.61% | |
depreciation and amortization | 36K - | 161K 347.22% | 206K 27.95% | 70K 66.02% | 54K 22.86% | 26K 51.85% | 27K 3.85% | 50K 85.19% | 1.25M 2,406% | ||
total other income expenses net | 40K - | 108K 170% | 127K 17.59% | 168K 32.28% | 233K 38.69% | 210K 9.87% | 48K 77.14% | 25K 47.92% | 1.87M 7,392% | 1.72M 8.06% | |
income before tax | -27.62M - | -48.05M 74.01% | -38.84M 19.17% | -21.12M 45.62% | -26.09M 23.51% | -28.62M 9.69% | -50.46M 76.33% | -92.29M 82.88% | -110.22M 19.43% | -116.66M 5.84% | |
income tax expense | -36K - | -161K 347.22% | -206K 27.95% | -70K 66.02% | 233K 432.86% | -236K 201.29% | -75K 68.22% | -75K 0% | 4.79M 6,481.33% | ||
net income | -27.62M - | -48.05M 74.01% | -38.84M 19.17% | -21.12M 45.62% | -26.09M 23.51% | -28.38M 8.79% | -50.39M 77.54% | -92.21M 83.00% | -115.00M 24.72% | -116.66M 1.44% | |
weighted average shs out | 54 - | 94 74.07% | 195 107.45% | 391 100.51% | 1.63K 315.60% | 8.04K 394.89% | 472.96K 5,781.10% | 1.82M 285.23% | 35.74M 1,861.56% | 17.04B 47,577.00% | |
weighted average shs out dil | 54 - | 94 74.07% | 195 107.45% | 391 100.51% | 1.63K 315.60% | 8.04K 394.89% | 472.96K 5,781.10% | 1.82M 285.23% | 35.74M 1,861.56% | 17.04B 47,577.00% | |
eps | -511.41K - | -511.21K 0.04% | -199.19K 61.04% | -54.02K 72.88% | -16.05K 70.28% | -3.53K 78.02% | -106.54 96.98% | -50.61 52.50% | -3.22 93.64% | -0.01 99.79% | |
epsdiluted | -511.41K - | -511.21K 0.04% | -199.19K 61.04% | -54.02K 72.88% | -16.05K 70.28% | -3.53K 78.02% | -106.54 96.98% | -50.61 52.50% | -3.22 93.64% | -0.01 99.79% |
All numbers in USD (except ratios and percentages)